EEDi-5273

EEDi-5273 is a potent, orally bioavailable small molecule inhibitor of EED with an IC50 of ~0.2 nM. It demonstrates robust anti-tumor efficacy in preclinical models, inducing profound and durable tumor regression in vivo, making it a valuable chemical probe for oncology and epigenetics research.